Bollino D, Ma X, Tighe K, Casildo A, Richard K, Passaniti A
Int J Mol Sci. 2024; 25(23).
PMID: 39684800
PMC: 11641566.
DOI: 10.3390/ijms252313091.
Bollino D, Hameed K, Bhat A, Zarrabi A, Casildo A, Ma X
Cancer Metab. 2024; 12(1):19.
PMID: 38951899
PMC: 11218198.
DOI: 10.1186/s40170-024-00346-2.
Hameed K, Bollino D, Shetty A, Carter-Cooper B, Lapidus R, Emadi A
Front Oncol. 2024; 14:1326754.
PMID: 38690164
PMC: 11059989.
DOI: 10.3389/fonc.2024.1326754.
Bollino D, Claiborne J, Hameed K, Ma X, Tighe K, Carter-Cooper B
Front Oncol. 2022; 12:1035537.
PMID: 36578934
PMC: 9790920.
DOI: 10.3389/fonc.2022.1035537.
Aly N, El-Ahwany A, Ataya F, Saeed H
Protein J. 2020; 39(6):717-729.
PMID: 33106988
DOI: 10.1007/s10930-020-09932-x.
Improving the Treatment of Acute Lymphoblastic Leukemia.
Radadiya A, Zhu W, Coricello A, Alcaro S, Richards N
Biochemistry. 2020; 59(35):3193-3200.
PMID: 32786406
PMC: 7497903.
DOI: 10.1021/acs.biochem.0c00354.
What makes a good new therapeutic L-asparaginase?.
Beckett A, Gervais D
World J Microbiol Biotechnol. 2019; 35(10):152.
PMID: 31552479
DOI: 10.1007/s11274-019-2731-9.
Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis.
Ramirez-Paz J, Saxena M, Delinois L, Joaquin-Ovalle F, Lin S, Chen Z
PLoS One. 2018; 13(7):e0197643.
PMID: 30052638
PMC: 6063399.
DOI: 10.1371/journal.pone.0197643.
Development of Asparaginase II for Immunosensing: A Trade-Off between Receptor Density and Sensing Efficiency.
Charbonneau D, Aube A, Rachel N, Guerrero V, Delorme K, Breault-Turcot J
ACS Omega. 2018; 2(5):2114-2125.
PMID: 30023654
PMC: 6044767.
DOI: 10.1021/acsomega.7b00110.
Identification and structural analysis of an L-asparaginase enzyme from guinea pig with putative tumor cell killing properties.
Schalk A, Nguyen H, Rigouin C, Lavie A
J Biol Chem. 2014; 289(48):33175-86.
PMID: 25320094
PMC: 4246078.
DOI: 10.1074/jbc.M114.609552.
L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL).
Kwon Y, Chung H, Moon C, Yockman J, Park Y, Gitlin S
J Control Release. 2009; 139(3):182-9.
PMID: 19577600
PMC: 2755588.
DOI: 10.1016/j.jconrel.2009.06.027.
Covalent polymer-drug conjugates.
Elvira C, Gallardo A, Roman J, Cifuentes A
Molecules. 2007; 10(1):114-25.
PMID: 18007281
PMC: 6147706.
DOI: 10.3390/10010114.
L-asparaginase of Thermus thermophilus: purification, properties and identification of essential amino acids for its catalytic activity.
Pritsa A, Kyriakidis D
Mol Cell Biochem. 2001; 216(1-2):93-101.
PMID: 11216870
DOI: 10.1023/a:1011066129771.
L-Asparaginase from Proteus vulgaris.
Tosa T, Sano R, Yamamoto K, Nakamura M, Ando K
Appl Microbiol. 1971; 22(3):387-92.
PMID: 5000866
PMC: 376319.
DOI: 10.1128/am.22.3.387-392.1971.
Purification and properties of L-asparaginase from Serratia marcescens.
Boyd J, Phillips A
J Bacteriol. 1971; 106(2):578-87.
PMID: 4995652
PMC: 285133.
DOI: 10.1128/jb.106.2.578-587.1971.
Biochemical properties of yeast L-asparaginase.
Jones G, MORTIMER R
Biochem Genet. 1973; 9(2):131-46.
PMID: 4580009
DOI: 10.1007/BF00487443.
Physical properties and subunit structure of L-asparaginase isolated from Erwinia carotovora.
CAMMACK K, Marlborough D, Miller D
Biochem J. 1972; 126(2):361-79.
PMID: 4561025
PMC: 1178385.
DOI: 10.1042/bj1260361.
In vitro alterations of L-asparaginase activity of Tetrahymena pyriformis by lipids.
Tsirka S, Kyriakidis D
Mol Cell Biochem. 1988; 83(2):147-55.
PMID: 3143910
DOI: 10.1007/BF00226142.
Purification and properties of a membrane-bound L-asparaginase of Tetrahymena pyriformis.
Triantafillou D, GEORGATSOS J, Kyriakidis D
Mol Cell Biochem. 1988; 81(1):43-51.
PMID: 3139990
DOI: 10.1007/BF00225652.
Analysis of the Escherichia coli gene encoding L-asparaginase II, ansB, and its regulation by cyclic AMP receptor and FNR proteins.
Jennings M, Beacham I
J Bacteriol. 1990; 172(3):1491-8.
PMID: 2407723
PMC: 208625.
DOI: 10.1128/jb.172.3.1491-1498.1990.
